Ricerca

Pubblicazioni IRIS

• Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
  Anno: 2025
• Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
  Anno: 2024
• Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients
  Anno: 2024
• Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center
  Anno: 2023
• Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity
  Anno: 2023